Perrigo Price to Free Cash Flow Ratio 2012-2026 | PRGO
Historical price to free cash flow ratio values for Perrigo (PRGO) since 2012.
| Perrigo Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-12 | 10.99 | 197978239619207008.00 | |
| 2025-12-31 | 13.27 | $0.00 | 0.00 |
| 2025-09-30 | 20.77 | $2.01 | 10.34 |
| 2025-06-30 | 24.62 | $2.15 | 11.47 |
| 2025-03-31 | 25.56 | $1.60 | 16.02 |
| 2024-12-31 | 23.20 | $2.06 | 11.28 |
| 2024-09-30 | 23.44 | $1.40 | 16.80 |
| 2024-06-30 | 22.73 | $1.72 | 13.21 |
| 2024-03-31 | 28.21 | $2.11 | 13.35 |
| 2023-12-31 | 27.92 | $2.28 | 12.26 |
| 2023-09-30 | 27.47 | $2.28 | 12.05 |
| 2023-06-30 | 28.97 | $1.70 | 17.05 |
| 2023-03-31 | 30.35 | $1.12 | 27.10 |
| 2022-12-31 | 28.63 | $1.76 | 16.29 |
| 2022-09-30 | 29.70 | $-0.72 | 0.00 |
| 2022-06-30 | 33.56 | $1.44 | 23.27 |
| 2022-03-31 | 31.58 | $0.98 | 32.33 |
| 2021-12-31 | 31.73 | $0.03 | 1010.54 |
| 2021-09-30 | 38.35 | $1.46 | 26.22 |
| 2021-06-30 | 36.93 | $-0.66 | 0.00 |
| 2021-03-31 | 32.43 | $2.05 | 15.79 |
| 2020-12-31 | 35.63 | $3.40 | 10.50 |
| 2020-09-30 | 36.41 | $3.37 | 10.79 |
| 2020-06-30 | 43.64 | $4.00 | 10.91 |
| 2020-03-31 | 37.82 | $2.30 | 16.46 |
| 2019-12-31 | 40.48 | $1.83 | 22.09 |
| 2019-09-30 | 43.61 | $2.58 | 16.92 |
| 2019-06-30 | 36.99 | $2.71 | 13.66 |
| 2019-03-31 | 37.24 | $2.96 | 12.58 |
| 2018-12-31 | 29.84 | $3.55 | 8.42 |
| 2018-09-30 | 54.36 | $3.76 | 14.47 |
| 2018-06-30 | 55.83 | $4.14 | 13.47 |
| 2018-03-31 | 63.66 | $4.20 | 15.15 |
| 2017-12-31 | 66.42 | $4.28 | 15.52 |
| 2017-09-30 | 64.39 | $4.30 | 14.97 |
| 2017-06-30 | 57.33 | $4.36 | 13.16 |
| 2017-03-31 | 50.29 | $4.58 | 10.97 |
| 2016-12-31 | 62.91 | $3.83 | 16.43 |
| 2016-09-30 | 69.68 | $0.05 | 1416.20 |
| 2016-06-30 | 68.32 | $2.05 | 33.36 |
| 2016-03-31 | 96.24 | $0.23 | 409.90 |
| 2015-12-31 | 108.74 | $0.84 | 129.05 |
| 2015-09-30 | 118.08 | $5.19 | 22.77 |
| 2015-06-30 | 138.68 | $3.07 | 45.20 |
| 2015-03-31 | 124.13 | $2.03 | 61.13 |
| 2014-12-31 | 125.24 | $3.07 | 40.82 |
| 2014-09-30 | 112.45 | $2.00 | 56.35 |
| 2014-06-30 | 109.05 | $1.44 | 75.53 |
| 2014-03-31 | 115.62 | $0.18 | 627.36 |
| 2013-12-31 | 114.65 | $1.44 | 79.41 |
| 2013-09-30 | 92.12 | $2.36 | 39.05 |
| 2013-06-30 | 90.27 | $2.01 | 44.83 |
| 2013-03-31 | 88.52 | $2.96 | 29.86 |
| 2012-12-31 | 77.49 | $2.01 | 38.48 |
| 2012-09-30 | 86.46 | $1.69 | 51.06 |
| 2012-06-30 | 87.70 | $1.75 | 50.15 |
| 2012-03-31 | 76.77 | $2.20 | 34.93 |
| 2011-12-31 | 72.25 | $1.75 | 41.31 |
| 2011-09-30 | 72.04 | $1.53 | 47.19 |
| 2011-06-30 | 65.14 | $0.99 | 65.97 |
| 2011-03-31 | 58.90 | $0.93 | 63.28 |
| 2010-12-31 | 46.86 | $0.99 | 47.46 |
| 2010-09-30 | 47.47 | $0.95 | 49.71 |
| 2010-06-30 | 43.61 | $1.43 | 30.54 |
| 2010-03-31 | 43.31 | $2.69 | 16.11 |
| 2009-12-31 | 29.34 | $1.43 | 20.54 |
| 2009-09-30 | 25.00 | $0.52 | 47.89 |
| 2009-06-30 | 20.39 | $0.16 | 126.82 |
| 2009-03-31 | 18.19 | $-0.21 | 0.00 |
| 2008-12-31 | 23.61 | $0.16 | 146.80 |
| 2008-09-30 | 28.05 | $0.54 | 51.78 |
| 2008-06-30 | 23.14 | $0.83 | 27.80 |
| 2008-03-31 | 27.44 | $1.45 | 18.91 |
| 2007-12-31 | 25.42 | $0.83 | 30.54 |
| 2007-09-30 | 15.48 | $0.40 | 38.78 |
| 2007-06-30 | 14.17 | $0.01 | 0.00 |
| 2007-03-31 | 12.75 | $-0.47 | 0.00 |
| 2006-12-31 | 12.46 | $0.01 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.495B | $4.253B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |